Edition:
United Kingdom

Pharma Mar SA (PHMR.MC)

PHMR.MC on Madrid SE C.A.T.S.

2.58EUR
18 Jan 2018
Change (% chg)

-- (--)
Prev Close
€2.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
931,882
52-wk High
€4.26
52-wk Low
€2.04

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 51.45 -0.018
Mar '17 45.47 -0.011
FY 2016 Dec '16 41.33 -0.035
Sep '16 47.49 -0.015
Jun '16 49.96 -0.027
Mar '16 42.17 -0.032
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 48.90 48.90 48.90 --
Quarter Ending Jun-18 1 54.70 54.70 54.70 --
Year Ending Dec-18 6 186.62 202.00 170.10 208.16
Earnings (per share)
Quarter Ending Mar-18 1 -0.00 -0.00 -0.00 --
Quarter Ending Jun-18 1 -0.01 -0.01 -0.01 --
Year Ending Dec-18 6 0.01 0.12 -0.07 0.10
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. 84.28 40.98 46.03
P/E Low - Last 5 Yrs. 15.44 23.80 24.39
Beta 1.53 0.90 0.89
Price to Sales (TTM) 3.72 3.98 5.45
Price to Book (MRQ) 14.56 4.82 5.38
Price to Tangible Book (MRQ) 33.09 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions -- 1.23 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3.00 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago -2.80 4.69 5.44
Sales - 5 Yr. Growth Rate 0.42 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 33.42 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -76.99 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate 14.81 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.08 2.11 2.18
Current Ratio (MRQ) 1.35 2.88 2.97
LT Debt to Equity (MRQ) 157.04 9.81 12.10
Total Debt to Equity (MRQ) 220.41 13.80 16.38
Interest Coverage (TTM) -1.13 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 75.43 55.13 54.76
Gross Margin - 5 Yr. Avg. 76.52 52.41 52.45
EBITD Margin (TTM) -3.61 -- --
EBITD - 5 Yr. Avg 8.86 18.54 15.33
Operating Margin (TTM) -7.44 14.40 7.60
Operating Margin - 5 Yr. Avg. 5.43 14.46 10.79
Pre-Tax Margin (TTM) -10.25 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. 2.22 14.77 11.19
Net Profit Margin (TTM) -9.89 11.09 4.70
Net Profit Margin - 5 Yr. Avg. 2.57 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -16.02 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 260,508 948,195,516 855,725,041
Net Income/Employee (TTM) -25,763 111,561,295 100,665,186
Receivable Turnover (TTM) 3.48 5.61 5.76
Inventory Turnover (TTM) 1.85 2.57 3.34
Asset Turnover (TTM) 0.84 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -8.30 11.41 10.97
Return on Assets - 5 Yr. Avg. 2.16 12.98 12.39
Return on Investment (TTM) -13.41 14.84 14.40
Return on Investment - 5 Yr. Avg. 3.48 16.97 16.20
Return on Equity (TTM) -33.49 16.32 16.09
Return on Equity - 5 Yr. Avg. 8.88 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -6.64 8.46 0.42
EPS (TTM) % -466.59 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pharma Mar SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -16.44 -16.90 20 25
13 Week -19.27 -16.87 58 36
26 Week 6.53 10.12 99 31
52 Week 11.91 -3.78 99 12
YTD 14.39 5.03 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.14%
# of Holders: 69
Total Shares Held: 31,475,116
3 Mo. Net Change: 683,473
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 9
# Reduced Positions: 5
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.